Jiangsu Recbio Technology Co., Ltd. (Stock Code: 2179) announced that it has obtained a filing notice dated January 13, 2026 from the China Securities Regulatory Commission (CSRC), confirming completion of the filing process for its planned H Share Full Circulation. According to the announcement, the filing covers the conversion of 141,953,489 previously unlisted shares held by 28 shareholders into H shares, and the filing notice will remain valid for 12 months from the date of issuance.

The total of 152,214,543 unlisted shares was held by various individuals and entities, with each shareholder specifying the portion of their unlisted holdings for full circulation. Most shareholders chose to convert their entire stake, while a few will partially convert their shares. The next step is to submit an application to The Stock Exchange of Hong Kong Limited for approval of the listing of and permission to deal in the newly converted H shares.

The announcement further indicates that details on implementing the H Share Full Circulation, as well as the conversion and listing, are yet to be finalized and remain subject to additional procedures from the Stock Exchange and other regulatory bodies in China and overseas. Shareholders and potential investors are advised to monitor subsequent updates on the progress and exercise caution in trading the company’s securities.